Resveratrol chemosensitizes HER-2-overexpressing breast cancer cells to docetaxel chemoresistance by inhibiting docetaxel-mediated activation of HER-2

Resveratrol chemosensitizes HER-2-overexpressing breast cancer cells to docetaxel chemoresistance by inhibiting docetaxel-mediated activation of HER-2–Akt axis

Published:2015-12 Issue:1 Volume:1 Page:
ISSN:2058-7716
Container-title:Cell Death Discovery
language:en
Short-container-title:Cell Death Discovery

Author:

Vinod B S,Nair H H,Vijayakurup V,Shabna A,Shah S,Krishna A,Pillai K S,Thankachan S,Anto R J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/cddiscovery201561.pdf

Reference33 articles.

1. Sui M, Zhang H, Fan W . The role of estrogen and estrogen receptors in chemoresistance. Curr Med Chem 2011; 18: 4674–4683.

2. Zhang W, Ding W, Chen Y, Feng M, Ouyang Y, Yu Y et al. Up-regulation of breast cancer resistance protein plays a role in HER2-mediated chemoresistance through PI3K/Akt and nuclear factor-kappa B signaling pathways in MCF7 breast cancer cells. Acta Biochim Biophys Sin (Shanghai) 2011; 43: 647–653.

3. Lumachi F, Luisetto G, Basso SM, Basso U, Brunello A, Camozzi V . Endocrine therapy of breast cancer. Curr Med Chem 2011; 18: 513–522.

4. Li SG, Li L . Targeted therapy in HER2-positive breast cancer. Biomed Rep 2013; 1: 499–505.

5. Fink MY, Chipuk JE . Survival of HER2-positive breast cancer cells: receptor signaling to apoptotic control centers. Genes Cancer 2013; 4: 187–195.

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytochemicals as Potential Lead Molecules against Hepatocellular Carcinoma;Current Medicinal Chemistry;2024-10

2. Interactions between Dietary Antioxidants, Dietary Fiber and the Gut Microbiome: Their Putative Role in Inflammation and Cancer;International Journal of Molecular Sciences;2024-07-28

3. Enhancing drug and cell line representations via contrastive learning for improved anti-cancer drug prioritization;npj Precision Oncology;2024-05-18

4. Designing JAK2 Inhibitors Beyond Myeloproliferative Neoplasms ‐ Theoretical and Experimental Analysis for Solid Cancers;ChemistrySelect;2024-05-15

5. Phyto-therapeutics as anti-cancer agents in breast cancer: Pathway targeting and mechanistic elucidation;Saudi Journal of Biological Sciences;2024-03